News
DBT and NSF Chiefs discuss biological manufacturing strategies at ABLE BIRAC joint meeting in Bengaluru
The key topic was to promote Indo-US collaborations in biotech innovation and biological manufacturing opportunities to reach the target of $ 100 billion biological manufacturing by 2030 from the current $ 40 billion level.
Amended Biodiversity laws are more biotech friendly now say ABLE experts
Dr Malathi and Mr Ravi highlighted the 8 key amendments that will ease the way for doing biotech business in the country using natural resources.
